Genome-free viral capsids as multivalent carriers for taxol delivery.
作者信息
Wu Wesley, Hsiao Sonny C, Carrico Zachary M, Francis Matthew B
机构信息
Department of Chemistry, University of California, Berkeley and Materials Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720-1460, USA.
出版信息
Angew Chem Int Ed Engl. 2009;48(50):9493-7. doi: 10.1002/anie.200902426.
Abstract
摘要
相似文献
1
Genome-free viral capsids as multivalent carriers for taxol delivery.
Angew Chem Int Ed Engl. 2009;48(50):9493-7. doi: 10.1002/anie.200902426.
2
Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery.
Pharm Res. 2015 Apr;32(4):1325-40. doi: 10.1007/s11095-014-1537-6. Epub 2014 Oct 16.
3
A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
Acta Biomater. 2010 Jun;6(6):2045-52. doi: 10.1016/j.actbio.2009.11.035. Epub 2009 Dec 5.
4
Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model.
J Control Release. 2016 Mar 10;225:240-51. doi: 10.1016/j.jconrel.2016.01.053. Epub 2016 Jan 29.
5
pH shift assembly of adenoviral serotype 5 capsid protein nanosystems for enhanced delivery of nanoparticles, proteins and nucleic acids.
J Control Release. 2013 Nov 28;172(1):341-350. doi: 10.1016/j.jconrel.2013.08.023. Epub 2013 Sep 1.
6
A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.
Angew Chem Int Ed Engl. 2013 Apr 8;52(15):4141-6. doi: 10.1002/anie.201209804. Epub 2013 Mar 11.
7
Functionalized nanospheres for targeted delivery of paclitaxel.
J Control Release. 2013 Nov 10;171(3):315-21. doi: 10.1016/j.jconrel.2013.06.017. Epub 2013 Jun 20.
8
QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells.
Nanomedicine (Lond). 2024;19(26):2211-2227. doi: 10.1080/17435889.2024.2353557. Epub 2024 Jun 27.
9
Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.
Pharm Res. 2016 Jun;33(6):1426-39. doi: 10.1007/s11095-016-1884-6. Epub 2016 Feb 23.
10
Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system.
Macromol Biosci. 2011 Sep 9;11(9):1264-71. doi: 10.1002/mabi.201100083. Epub 2011 Jun 29.
引用本文的文献
1
Phage-based delivery systems: engineering, applications, and challenges in nanomedicines.
J Nanobiotechnology. 2024 Jun 25;22(1):365. doi: 10.1186/s12951-024-02576-4.
2
Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases.
Pharmaceutics. 2023 Jul 11;15(7):1931. doi: 10.3390/pharmaceutics15071931.
3
Fitness Landscape-Guided Engineering of Locally Supercharged Virus-like Particles with Enhanced Cell Uptake Properties.
ACS Chem Biol. 2022 Dec 16;17(12):3367-3378. doi: 10.1021/acschembio.2c00318. Epub 2022 Nov 15.
4
Biomimetic Nanovesicles-Sources, Design, Production Methods, and Applications.
Pharmaceutics. 2022 Sep 22;14(10):2008. doi: 10.3390/pharmaceutics14102008.
5
Advancement and Applications of Platelet-inspired Nanoparticles: A Paradigm for Cancer Targeting.
Curr Pharm Biotechnol. 2023;24(2):213-237. doi: 10.2174/1389201023666220329111920.
6
Exploiting Complex Fluorophore Interactions to Monitor Virus Capsid Disassembly.
Molecules. 2021 Sep 22;26(19):5750. doi: 10.3390/molecules26195750.
7
Delivery of cancer therapies by synthetic and bio-inspired nanovectors.
Mol Cancer. 2021 Mar 24;20(1):55. doi: 10.1186/s12943-021-01346-2.
8
Bacteriophage Capsid Modification by Genetic and Chemical Methods.
Bioconjug Chem. 2021 Mar 17;32(3):466-481. doi: 10.1021/acs.bioconjchem.1c00018. Epub 2021 Mar 4.
9
Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment.
Molecules. 2020 Dec 16;25(24):5952. doi: 10.3390/molecules25245952.
10
Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine-Cysteine Bond Formation.
ACS Cent Sci. 2020 Sep 23;6(9):1564-1571. doi: 10.1021/acscentsci.0c00940. Epub 2020 Aug 21.
本文引用的文献
1
Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles.
J Am Chem Soc. 2009 Aug 12;131(31):11174-8. doi: 10.1021/ja903857f.
2
Drug delivery with carbon nanotubes for in vivo cancer treatment.
Cancer Res. 2008 Aug 15;68(16):6652-60. doi: 10.1158/0008-5472.CAN-08-1468.
3
Nanocarriers as an emerging platform for cancer therapy.
Nat Nanotechnol. 2007 Dec;2(12):751-60. doi: 10.1038/nnano.2007.387.
4
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
J Control Release. 2008 Dec 18;132(3):171-83. doi: 10.1016/j.jconrel.2008.05.010. Epub 2008 May 17.
5
The design of polyvalent therapeutics.
Chemistry. 2008;14(26):7738-47. doi: 10.1002/chem.200800278.
6
Therapeutic and diagnostic applications of dendrimers for cancer treatment.
Adv Drug Deliv Rev. 2008 Jun 10;60(9):1037-55. doi: 10.1016/j.addr.2008.02.012. Epub 2008 Mar 4.
7
Genome-free viral capsids as carriers for positron emission tomography radiolabels.
Mol Imaging Biol. 2008 Jul-Aug;10(4):182-91. doi: 10.1007/s11307-008-0136-5. Epub 2008 Apr 25.
8
Protein nanoparticles as drug carriers in clinical medicine.
Adv Drug Deliv Rev. 2008 May 22;60(8):876-85. doi: 10.1016/j.addr.2007.08.044. Epub 2008 Feb 7.
9
Ester bonds in prodrugs.
ACS Chem Biol. 2008 Apr 18;3(4):203-6. doi: 10.1021/cb800065s.
10
Oxidative coupling of peptides to a virus capsid containing unnatural amino acids.
Chem Commun (Camb). 2008 Mar 14(10):1205-7. doi: 10.1039/b717826c. Epub 2008 Jan 29.
Zotero 插件